ABILIFY MYCITE KIT

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Nov 13, 2017

   8 yr 9 mo ago

2. Patent 11476952 expires

   Listed drug product patent expiration.

   Apr 28, 2026

   2 mo ago

3. Today

4. Patent 9125939 expires

   Listed method-of-use patent (U-1749) expiration.

   Jul 28, 2026

   in 1 mo

5. Patent 7978064 expires

   Listed drug product patent expiration.

   Sep 14, 2026

   in 3 mo

6. Patent 8759350 expires

   Listed method-of-use patent (U-1529) expiration.

   Mar 02, 2027

   in 9 mo

7. Patent 9444503 expires

   Listed drug product patent expiration.

   Nov 19, 2027

   in 1 yr 5 mo

8. Patent 9119554 expires

   Listed drug product patent expiration.

   Dec 16, 2028

   in 2 yr 6 mo

9. Patent 9060708 expires

   Listed drug product patent expiration.

   Mar 05, 2029

   in 2 yr 9 mo

10. Patent 9258035 expires

    Listed drug product patent expiration.

    Mar 05, 2029

    in 2 yr 9 mo

11. Patent 8674825 expires

    Listed drug product patent expiration.

    Apr 09, 2029

    in 2 yr 10 mo

12. Patent 8956288 expires

    Listed drug product patent expiration.

    Jul 06, 2029

    in 3 yr 1 mo

13. Patent 10441194 expires

    Listed drug product patent expiration.

    Jul 26, 2029

    in 3 yr 2 mo

14. Patent 8945005 expires

    Listed drug product patent expiration.

    Aug 19, 2029

    in 3 yr 3 mo

15. Patent 9433371 expires

    Listed drug product patent expiration.

    Sep 15, 2029

    in 3 yr 3 mo

16. Patent 8718193 expires

    Listed drug product patent expiration.

    Dec 05, 2029

    in 3 yr 6 mo

17. Patent 9149577 expires

    Listed drug product patent expiration.

    Dec 15, 2029

    in 3 yr 7 mo

18. Patent 8847766 expires

    Listed drug product patent expiration.

    Mar 29, 2030

    in 3 yr 10 mo

19. Patent 8545402 expires

    Listed drug product patent expiration.

    Apr 27, 2030

    in 3 yr 11 mo

20. Patent 8114021 expires

    Listed drug product patent expiration.

    Jun 21, 2030

    in 4 yr 1 mo

21. Patent 11464423 expires

    Listed drug product patent expiration.

    Sep 15, 2030

    in 4 yr 4 mo

22. Patent 9941931 expires

    Listed drug product patent expiration.

    Nov 04, 2030

    in 4 yr 5 mo

23. Patent 8961412 expires

    Listed drug product patent expiration.

    Nov 17, 2030

    in 4 yr 6 mo

24. Patent 8258962 expires

    Listed drug product patent expiration.

    Nov 25, 2030

    in 4 yr 6 mo

25. Patent 8547248 expires

    Listed drug product patent expiration.

    Dec 18, 2030

    in 4 yr 7 mo

26. Patent 11229378 expires

    Listed drug product patent expiration.

    Jul 11, 2031

    in 5 yr 2 mo

27. Patent 9320455 expires

    Listed drug product patent expiration.

    Dec 15, 2031

    in 5 yr 7 mo

28. Patent 10517507 expires

    Listed drug product patent expiration.

    Jun 13, 2032

    in 6 yr 1 mo

29. Patent 9268909 expires

    Listed drug product patent expiration.

    Oct 15, 2033

    in 7 yr 5 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

• MEZOFYBrand (NDA)

  NDA 211448 · CMG PHARM CO LTD

  2025
• OPIPZABrand (NDA)

  NDA 216655 · XIAMEN LP PHARM CO

  2024
• ABILIFY ASIMTUFIIBrand (NDA)

  NDA 217006 · OTSUKA

  2023
• ABILIFY MAINTENA KITBrand (NDA)

  NDA 202971 · OTSUKA PHARM CO LTD

  2013
• ABILIFYBrand (NDA)

  NDA 021866 · OTSUKA

  2006
• ABILIFYBrand (NDA)

  NDA 021729 · OTSUKA

  2006
• ABILIFYBrand (NDA)

  NDA 021713 · OTSUKA

  2004
• ABILIFYBrand (NDA)

  NDA 021436 · OTSUKA

  2002
• ARIPIPRAZOLEGeneric (ANDA)

  ANDA 216208 · AUROBINDO PHARMA

  2026
• ARIPIPRAZOLEGeneric (ANDA)

  ANDA 215582 · QUAGEN

  2025
• ARIPIPRAZOLEGeneric (ANDA)

  ANDA 216608 · MYLAN

  2024
• ARIPIPRAZOLEGeneric (ANDA)

  ANDA 205589 · LUPIN

  2024

Listed patents (27)